Results 251 to 260 of about 721,729 (294)

Monocyte C1‐inhibitor synthesis in patients with C1‐inhibitor deficiency

European Journal of Clinical Investigation, 1989
Abstract. Monocytes of seven out of eight patients with type 1 C1‐inhibitor (C1‐inh) deficiency (HAE) produced 40% as much C1‐inh as monocytes from normal donors (controls). In contrast, monocytes from three patients with type 2 and three patients with acquired C1‐inh deficiency produced similar amounts of Cl‐inh as controls. Recombinant γ‐interferon (
D F, Lappin, A R, McPhaden, P L, Yap, P E, Carter, G D, Birnie, J E, Fothergill, K, Whaley   +6 more
openaire   +3 more sources

C1 Inhibitor Autoantibodies

, 2014
Autoantibodies to C1 inhibitor (C1-INH) bind to epitopes on the reactive center of the C1-INH molecule. As a consequence of this binding, C1-INH is converted into an inactive substrate that can be cleaved by proteases. C1-INH is a serine protease inhibitor that plays a role in the complement, contact, fibrinolytic, and coagulation cascades ...
Zanichelli, A, Suffritti, C, Cicardi, M, PERRICONE, ROBERTO   +3 more
openaire   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Deficiencies of C1 inhibitor

Best Practice & Research Clinical Gastroenterology, 2005
Hereditary and acquired deficiencies of the C1 inhibitor result in a single prominent symptom, namely angioedema. Angioedema may involve the skin, the gastrointestinal tract or the upper airway. Genetically determined defects in C1INH cause hereditary angioedema.
Fred S, Rosen, Alvin E, Davis
openaire   +2 more sources

Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency

Journal of Allergy and Clinical Immunology, 2006
BACKGROUND: Administration of C1-inhibitor concentrate is effective for prophylaxis and treatment of severe angioedema attacks caused by C1-inhibitor deficiency.
, C Erik Hack
exaly   +2 more sources

[C1-inhibitor].

Nihon rinsho. Japanese journal of clinical medicine, 2000
Ranol Zahedi, Alvin E. Davis
openaire   +4 more sources

C1 inhibitor deficiency

Clinical and Experimental Dermatology, 2005
M, Darling, M L, Price
openaire   +2 more sources

Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment

Cell, 2023
Steven J Mullett, Marlies Meisel
exaly  

C1-inhibitor synthesis by monocytes of patients with C1-inhibitor deficiency

Biochemical Society Transactions, 1987
LINDA JONES, PENG-LEE YAP, ALBERT C. YEUNG-LAIWEH, KEITH WHALEY   +3 more
openaire   +1 more source

C1 INHIBITOR IN MALIGNANT DISEASES

The Lancet, 1976
P J, Lachmann, J, Wragge-Morley
openaire   +2 more sources

The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y 12 Inhibitor in Patients After Percutaneous Coronary Intervention

Circulation, 2020
Michelle L O'Donoghue, Marc S Sabatine
exaly